The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $112.45

Today's change+0.14 +0.12%
Updated January 24 4:15 PM EST. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $112.45

Today's change+0.14 +0.12%
Updated January 24 4:15 PM EST. Delayed by at least 15 minutes.

Celgene Corp up (U.S.)$0.14

Celgene Corp closed up Tuesday by (U.S.)$0.14 or 0.12% to (U.S.)$112.45. Shares have lost 2.17% for the last five days, but have gained 3.35% over the last 52 weeks. This security has underperformed the S&P 500 by 16.22% during the last year.

Key company metrics

  • Open(U.S.) $112.75
  • Previous close(U.S.) $112.31
  • High(U.S.) $113.00
  • Low(U.S.) $111.26
  • Bid / Ask(U.S.) $111.34 / (U.S.) $113.11
  • YTD % change-2.85%
  • Volume3,230,872
  • Average volume (10-day)5,054,128
  • Average volume (1-month)4,163,971
  • Average volume (3-month)4,560,262
  • 52-week range(U.S.) $93.05 to (U.S.) $127.00
  • Beta1.74
  • Trailing P/E42.62×
  • P/E 1 year forward18.96×
  • Forward PEG0.83×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.64
Updated January 24 4:15 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,9832,7542,5122,563
Total other revenue--------
Total revenue2,9832,7542,5122,563
Gross profit2,8752,6432,4062,458
Total cost of revenue108111106105
Total operating expense2,6171,9631,4881,685
Selling / general / administrative698732543609
Research & development1,654949733777
Depreciation / amortization871759288
Interest expense (income), net operating--------
Unusual expense (income)71-414105
Other operating expenses, total--------
Operating income3667921,024879
Interest income (expense), net non-operating-137-136-135-139
Gain (loss) on sale of assets--------
Other--------
Income before tax257695922746
Income after tax171598801561
Income tax, total8597121185
Net income171598801561
Total adjustments to net income--------
Net income before extra. items171598801561
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items171598801561
Inc. avail. to common incl. extra. items171598801561
Diluted net income171598801561
Dilution adjustment--------
Diluted weighted average shares802802808817
Diluted EPS excluding extraordinary itemsvalue per share0.210.750.990.69
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.270.741.010.78